株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品市場のICT投資の動向:企業のICT支出パターンの見通し

ICT investment trends in pharmaceuticals ; Enterprise ICT spending patterns through to the end of 2016

発行 Kable 商品コード 314911
出版日 ページ情報 英文 83 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
医薬品市場のICT投資の動向:企業のICT支出パターンの見通し ICT investment trends in pharmaceuticals ; Enterprise ICT spending patterns through to the end of 2016
出版日: 2015年11月27日 ページ情報: 英文 83 Pages
概要

当レポートでは、製薬企業113社を対象に実施した、情報通信技術(ICT)の投資動向に関する調査結果に基づき、企業のICT支出の中核分野(ハードウェア、ソフトウェア、ITサービス、通信、コンサルティング)にICT予算をどのように配分するか、その現状について検証して、体系的な情報を提供しています。

第1章 ICT予算の動向

  • イントロダクション
  • 調査人口統計
  • ICT予算の変化
  • ICT予算の配分:中核技術分野別
    • ハードウェア予算の内訳
    • ソフトウェア予算の内訳
    • サードパーティITサービス支出
    • 通信予算
  • ICT予算の配分:機能別
  • IT機能のアウトソース

第2章 ICT投資の優先順位とベンダーのマインドシェア

  • イントロダクション
    • ビジネスインテリジェンス(BI)
    • モビリティ
    • クラウドコンピューティング

第3章 ICT調達の動向

  • イントロダクション
  • IT投資戦略に影響を与える業務目標
  • IT投資戦略に影響を与えるIT目標
  • ICTプロバイダーの選定

第4章 部門別の動向

  • イントロダクション
  • 固有の事業分野に対するIT支出計画
  • 最大の投資の事業分野
  • ビジネス上の課題

第5章 サマリー

第6章 付録

  • 定義
  • 関連調査
  • 連絡先

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KG0189CI

Summary

The pharmaceutical industry is in the midst of fundamental changes, brought on by the increasing concerns over the expiry of patents, weak product pipelines, and competition from generics. However, increasing prosperity in emerging markets is creating new avenues for pharmaceutical companies to increase their top-line growth. Thus, to meet the challenges and exploit the opportunities, pharmaceutical companies are increasingly looking towards advanced technologies to stay ahead of the intense competition in the field.

Key Findings

To offset declining sales from the patent cliff, companies are expanding into emerging markets in order to increase their market share, which is in turn leading to increasing investments in their core ICT categories of hardware, software, and IT services.

Kable expects mobility and cloud computing to gain momentum in the next two years, and companies are set to increase spending on these advance technologies in order to enhance their competitiveness.

Meanwhile, pharmaceutical companies are prioritizing their ICT investments relating to clinical and pre-clinical research to drive future RandD requirements.

Synopsis

ICT investment trends in pharmaceuticals presents the findings from a survey of 95 pharmaceutical companies regarding their Information and Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.

The report illustrates the core technologies banks are investing in, including business intelligence, mobility and cloud computing. Understand the approach adopted by pharmaceutical companies to purchase technology and get a better insight into ICT vendors and services providers when pitching their solutions to pharmaceutical companies. The report also focuses on pharmaceutical companies' ICT spending trends for specific business systems, identifying the top three IT projects, and understanding the business challenges faced by companies.

In particular, it provides an in-depth analysis of the following:

  • How ICT budgets are set to change in 2015 in terms of their overall size
  • Allocation across the core elements of IT spend, including hardware, software, services, communications, and consulting
  • Distribution of ICT money in areas such as the networks, applications, service desk, and data centers
  • Which ICT functions pharmaceutical companies are interested in outsourcing
  • Pharmaceuticals' investment priorities based on their budget allocations across core technology categories such as business intelligence, mobility, and cloud computing
  • Factors that are influencing pharmaceutical companies' investments in each technology category
  • How pharmaceutical companies' IT budgets are currently allocated across various segments within a technology category
  • Pharmaceutical companies' distribution of their ICT budget across various segments within a technology category
  • Vendor satisfaction ratings for various core and advanced technology categories
  • Insight into pharmaceutical companies' preferred buying approaches
  • Business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies
  • Factors that are influencing pharmaceutical companies' decisions to select an ICT provider

Reasons To Buy

  • Understand how the pharmaceutical companies ICT landscape is set to change in 2015 to prioritize your target market
  • Comprehend how ICT money are being allocated by pharmaceutical companies in specific geographies and size bands to improve your market penetration
  • Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting)
  • Realign your sales initiatives by understanding the current strategic objectives of pharmaceutical companies
  • Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (business intelligence, mobility, and cloud computing)
  • Prioritize your focus areas by understanding which factors are influencing pharmaceutical companies' decisions when selecting an ICT provider
  • Understand the changes in customers' priorities and identify the business and IT objectives that pharmaceutical companies are looking to achieve through their ICT investment strategies

Table of Contents

1. Trends in ICT budgets

  • 1.1. Introduction
  • 1.2. Survey demographics
  • 1.3. ICT budget changes
  • 1.4. ICT budget allocation by core technology area
    • 1.4.1. Hardware budget breakdown
    • 1.4.2. Software budget breakdowns
    • 1.4.3. Third party IT services expenditure
    • 1.4.4. Cloud computing budget
  • 1.5. ICT budget allocation by function
  • 1.6. Outsourced IT functions

2. ICT investment priorities and vendor satisfaction

  • 2.1. Introduction
    • 2.1.1. Business intelligence
    • 2.1.2. Mobility
    • 2.1.3. Cloud computing

3. ICT procurement trends

  • 3.1. Introduction
  • 3.2. Business objectives and IT objectives influencing IT investment strategy
  • 3.3. ICT provider selection

4. Sector-specific trends

  • 4.1. Introduction
  • 4.2. IT expenditure plans for specific technology areas
  • 4.3. Business areas receiving the largest investments
  • 4.4. Business challenges

5. Summary

  • 5.1. Pharmaceutical companies are increasingly looking towards advanced technologies to stay ahead of the intense competition

6. Appendix

  • 6.1. Definitions
  • 6.2. Further reading
  • 6.3. Contact the authors

List of Figures

  • Figure 1: Pharmaceuticals - ICT survey geographic breakdown
  • Figure 2: Pharmaceuticals - ICT survey breakdown by size band (number of employees)
  • Figure 3: Recent and expected ICT budget changes among pharmaceutical companies
  • Figure 4: Pharmaceutical companies' (external) ICT budget allocation, 2014 and 2015
  • Figure 5: Pharmaceutical companies' average hardware budget allocation
  • Figure 6: Average allocation of software budgets in pharmaceutical companies
  • Figure 7: Pharmaceutical companies' average IT services budget allocation
  • Figure 8: Pharmaceutical companies' average cloud computing budget allocation by technology
  • Figure 9: Pharmaceutical companies' average cloud computing budget allocation by implementation type...
  • Figure 10:Pharmaceutical companies' ICT budget allocation by function, 2014 and 2015
  • Figure 11: Outsourced IT functions - Pharmaceutical companies' current and future outsourcing priorities
  • Figure 12: Business intelligence -Pharmaceutical companies' current and future investment priorities
  • Figure 13: Business intelligence - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 14:Mobility - Pharmaceutical companies' current and future investment priorities
  • Figure 15:Mobility - selected primary provider and vendor satisfaction among pharmaceutical companies.
  • Figure 16: Cloud computing - Pharmaceutical companies' current and future investment priorities
  • Figure 17: Cloud computing - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 18: Business objectives and IT objectives which influence pharmaceutical companies' IT investment strategy
  • Figure 19: Factors influencing pharmaceutical companies' decision to choose an ICT provider
  • Figure 20: IT expenditure plans in 2015 compared to 2014, for specific technology areas within pharmaceutical companies
  • Figure 21: Top three IT projects in 2015 for pharmaceutical companies
  • Figure 22: Importance of the following business challenges for pharmaceutical companies
Back to Top